December 8, 2016
Novartis gets eye disease drug European approval
European Commission (EC) has granted an additional indication for Novartis’s Lucentis (ranibizumab) to treat patients with eye disease due to…
Pharmaceuticals, Biotechnology and Life Sciences
European Commission (EC) has granted an additional indication for Novartis’s Lucentis (ranibizumab) to treat patients with eye disease due to…